ATE478065T1 - Verfahren zur herstellung von zusammensetzungen mit erhöhtem gehalt von salzen pharmazeutisch aktiver rotamere - Google Patents

Verfahren zur herstellung von zusammensetzungen mit erhöhtem gehalt von salzen pharmazeutisch aktiver rotamere

Info

Publication number
ATE478065T1
ATE478065T1 AT02784638T AT02784638T ATE478065T1 AT E478065 T1 ATE478065 T1 AT E478065T1 AT 02784638 T AT02784638 T AT 02784638T AT 02784638 T AT02784638 T AT 02784638T AT E478065 T1 ATE478065 T1 AT E478065T1
Authority
AT
Austria
Prior art keywords
rotamers
salts
pharmaceutically active
high content
producing compositions
Prior art date
Application number
AT02784638T
Other languages
English (en)
Inventor
Dinesh Gala
Andrew Goodman
Gary Lee
Hongbiao Liao
Martin Schwartz
Suhan Tang
David Tsai
Wenxue Wu
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE478065T1 publication Critical patent/ATE478065T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02784638T 2001-11-29 2002-11-26 Verfahren zur herstellung von zusammensetzungen mit erhöhtem gehalt von salzen pharmazeutisch aktiver rotamere ATE478065T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33433101P 2001-11-29 2001-11-29
US37391602P 2002-04-19 2002-04-19
PCT/US2002/038112 WO2003048153A1 (en) 2001-11-29 2002-11-26 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers

Publications (1)

Publication Number Publication Date
ATE478065T1 true ATE478065T1 (de) 2010-09-15

Family

ID=26989151

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02784638T ATE478065T1 (de) 2001-11-29 2002-11-26 Verfahren zur herstellung von zusammensetzungen mit erhöhtem gehalt von salzen pharmazeutisch aktiver rotamere

Country Status (11)

Country Link
US (2) US6943251B2 (de)
EP (1) EP1451174B1 (de)
JP (2) JP2005511693A (de)
CN (1) CN1596254A (de)
AR (1) AR037679A1 (de)
AT (1) ATE478065T1 (de)
AU (1) AU2002346569A1 (de)
CA (1) CA2468525A1 (de)
DE (1) DE60237388D1 (de)
MX (1) MXPA04005210A (de)
WO (1) WO2003048153A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689765B2 (en) * 1999-05-04 2004-02-10 Schering Corporation Piperazine derivatives useful as CCR5 antagonists
CN1596254A (zh) * 2001-11-29 2005-03-16 先灵公司 含有增加量的旋转异构体的药物活性盐的组合物的制备方法
MXPA04009428A (es) * 2002-03-29 2005-01-25 Schering Corp Sintesis de compuestos de piperidina y piperazina como antagonistas de ccr5.
US7244765B2 (en) * 2004-06-25 2007-07-17 Cytokine Pharmasciences, Inc Guanylhydrazone salts, compositions, processes of making and methods of using
CN101133048A (zh) * 2005-01-06 2008-02-27 先灵公司 哌嗪化合物的药用盐制备
WO2007038496A2 (en) * 2005-09-27 2007-04-05 Chemic Laboratories, Inc. Synthesis of fatty alcohol esters of hydroxy carboxylic acids, the use of the same as percutaneous permeation enhancers
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
US7561458B2 (en) * 2006-12-26 2009-07-14 Texas Instruments Incorporated Ferroelectric memory array for implementing a zero cancellation scheme to reduce plateline voltage in ferroelectric memory
TWI605814B (zh) 2010-03-11 2017-11-21 惠氏有限責任公司 甲基拿淬松（ｍｅｔｈｙｌｎａｌｔｒｅｘｏｎｅ）之口服製劑及親脂性鹽
US20170197980A1 (en) * 2014-06-25 2017-07-13 Abbvie Inc. N-(4-phenyl)-n'-(3-fluorophenyl)urea docusate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391865B1 (en) * 1999-05-04 2002-05-21 Schering Corporation Piperazine derivatives useful as CCR5 antagonists
SK286641B6 (sk) * 1999-05-04 2009-03-05 Schering Corporation Piperazínové deriváty užitočné ako CCR5 antagonisty, farmaceutické prípravky s ich obsahom a ich použitie
JP3874229B2 (ja) * 1999-07-02 2007-01-31 Ｔｄｋ株式会社 圧電セラミックスおよびこれを用いた圧電デバイス
CN1596254A (zh) * 2001-11-29 2005-03-16 先灵公司 含有增加量的旋转异构体的药物活性盐的组合物的制备方法

Also Published As

Publication number Publication date
AU2002346569A8 (en) 2003-06-17
US7534884B2 (en) 2009-05-19
HK1063798A1 (en) 2005-01-14
US20030144510A1 (en) 2003-07-31
AR037679A1 (es) 2004-12-01
WO2003048153A8 (en) 2004-06-03
JP2010132705A (ja) 2010-06-17
AU2002346569A1 (en) 2003-06-17
CA2468525A1 (en) 2003-06-12
EP1451174A2 (de) 2004-09-01
CN1596254A (zh) 2005-03-16
DE60237388D1 (de) 2010-09-30
US6943251B2 (en) 2005-09-13
US20050171117A1 (en) 2005-08-04
EP1451174B1 (de) 2010-08-18
JP2005511693A (ja) 2005-04-28
WO2003048153A1 (en) 2003-06-12
MXPA04005210A (es) 2004-08-19

Similar Documents

Publication Publication Date Title
DE60121970D1 (de) Verfahren zur herstellung von pfropfcopolymeren und daraus hergestellte zusammensetzungen
ATE325098T1 (de) Verfahren zur herstellung von 3- hydroxypicolinsäure-derivaten
DE122007000077I1 (de) Verfahren zur Herstellung von substituierten Octanoyl-Amiden
DE60323192D1 (de) Verfahren zur Herstellung von Hydroxyalkylstärkederivaten
ATE358123T1 (de) Verfahren zur herstellung von ivabradine und deren pharmazeutisch verträgliche säureadditionssalze
DE50201891D1 (de) Verfahren zur herstellung von 1-octen
ATE374463T1 (de) Verfahren zur herstellung von oxazolidinonen
DE60121150D1 (de) Verfahren zur herstellung von ansamitocin
DE50110603D1 (de) Kontinuierliches Verfahren zur Herstellung von Kohlensäurediarylestern
ATE316959T1 (de) Verfahren zur herstellung von 2- halogenpyridincarbonsäureamiden
DE60131954D1 (de) Verfahren zur herstellung von 2-hydroxy-4-methylthiobutansäure
DE60237388D1 (de) Verfahren zur herstellung von zusammensetzungen mit erhöhtem gehalt von salzen pharmazeutisch aktiver rotamere
DE50311721D1 (de) Verfahren zur Herstellung von Aryl-aminopropanolen
DE60108668D1 (de) Verfahren zur herstellung von phenethylamin-derivaten
DE50207455D1 (de) Verfahren ZUR HERSTELLUNG VON CARBONSÄURESALZEN
DE60233589D1 (de) Verfahren zur herstellung von echinocandinderivaten
ATE301634T1 (de) Verfahren zur herstellung von alpha- hydroxycarbonsäureamiden
ATE273315T1 (de) Verfahren zur herstellung von n- phosphonomethyliminodiessigsäure
DE60134415D1 (de) Verfahren zur herstellung von wäscheweichmacherzusammensetzungen
DE60104691D1 (de) Verfahren zur herstellung von pyrazolopyrimidinonen
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
DE60322356D1 (de) Verfahren zur herstellung von 2-aminoindanderivaten
DE50211253D1 (de) Verfahren zur Herstellung von Makrokapseln
DE60216161D1 (de) Verfahren zur herstellung von stabilen bacosiden angereicherter fraktion in nicht-hygroskopischer form
DE60301444T2 (de) Verfahren zur Herstellung von Polyalkylphenoxyaminoalkanen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties